Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Lixisenatide bij vroege Parkinson: minder progressie van motorische beperkingen
jun 2024 | Bewegingsstoornissen